ArticleOncology letters2025

Efficacy of combined immunotherapy and chemotherapy in recurrent non-small cell lung cancer during durvalumab maintenance therapy: A case report.

Yuki Maze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.